跳至主要内容
临床试验/NCT01486563
NCT01486563已完成4 期

Effect of Hydroxyethyl Starch on Renal Handling of Sodium and Water, Vasoactive Hormones,Biomarkers and the Circulatory System in Patients Undergoing Radical Prostatectomy

Regional Hospital Holstebro1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2012年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
u-NGAL

研究概览

简要总结

The purpose of this project is to investigate if hydroxyethyl starch (HES) is potential nephrotoxic and examine the effects on the circulation and kidneys during administration of HES during surgery.

详细描述

Hydroxyethyl starch (HES) is widely used in hospitals to maintain circulation in critically ill patients. In recent years studies have raised suspicion that HES is nephrotoxic. So far acute kidney injury has been diagnosed based on creatinine measurements, but new technology allows for earlier diagnosis using measurements of biomarkers in urine.

The purpose of this project is to investigate HES's potential toxicity and effects on the circulation and kidneys using measurements of biomarkers specific for toxicity and for the sodium/water balance in the urine and by measurements of vasoactive hormones in the blood after administration of HES 130/0.4

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Age > 18 years
  • Indication for radical prostatectomy

排除标准

  • Blood donation within the last month
  • Lack of wish to participate
  • eGFR< 15ml/min

研究组 & 干预措施

Voluven (Hydroxyethyl starch 130/0,4)

Active Comparator

Patients undergoing radical prostatectomy will receive either fluid therapy with active comparator (Voluven) or placebo (Sodium Chloride)

干预措施: Voluven (Hydroxyethyl starch 130/0,4) (Drug)

Sodium Chloride 9 mg/ml

Placebo Comparator

Patients undergoing radical prostatectomy will receive either fluid therapy with active comparator (Voluven) or placebo (Sodium Chloride)

干预措施: Sodium Chloride 9 mg/ml (Drug)

结局指标

主要结局

u-NGAL

时间窗: 2-4 hours

The main objective for the trial (only patients undergoing elective radical prostatectomy) is to measure the effect of hydroxyethyl starch on u-NGAL, which is a biomarker of nephrotoxicity

次要结局

  • u-Kim 1, u- FABP(2-4 hours)
  • FENa, u-ENaCβ, CH2O, u-AQP2,u-NCC, u-NK2CC(2-4 hours)
  • PRC, p-Ang-II, p -Aldo, p-ANP,P-GDP, p-AVP, p-Endot(2-4 hours)
  • SBP, DBP, heartrate(2-4 hours)

研究者

发起方
Regional Hospital Holstebro
申办方类型
Other
责任方
Principal Investigator
主要研究者

Erling Bjerregaard Pedersen

Professor

Regional Hospital Holstebro

研究点 (1)

Loading locations...

相似试验

Hydroxyethyl Starch and Renal Function After Radical... | 临床试验